Joshua J. Short, Ph.D. - Publications
Affiliations: | 2004 | University of Alabama, Birmingham, Birmingham, AL, United States | |
2013-2015 | Pediatric Surgery | Mott Children's Hospital, Ann Arbor, MI, United States | |
2015- | Pediatric Surgery | Children's Hospitals of Minnesota, Saint Paul, MN, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2010 | Short JJ, Rivera AA, Wu H, Walter MR, Yamamoto M, Mathis JM, Curiel DT. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy. Molecular Cancer Therapeutics. 9: 2536-44. PMID 20736345 DOI: 10.1158/1535-7163.Mct-10-0332 | 0.451 | |||
2009 | Short JJ, Curiel DT. Oncolytic adenoviruses targeted to cancer stem cells. Molecular Cancer Therapeutics. 8: 2096-102. PMID 19671759 DOI: 10.1158/1535-7163.Mct-09-0367 | 0.37 | |||
2006 | Short JJ, Vasu C, Holterman MJ, Curiel DT, Pereboev A. Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors. Virus Research. 122: 144-53. PMID 16920215 DOI: 10.1016/J.Virusres.2006.07.009 | 0.544 | |||
2004 | Short JJ, Pereboev AV, Kawakami Y, Vasu C, Holterman MJ, Curiel DT. Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors. Virology. 322: 349-59. PMID 15110532 DOI: 10.1016/J.Virol.2004.02.016 | 0.498 | |||
2004 | Short JJ, Pereboev AV, Kawakami Y, Vasu C, Holterman MJ, Curiel DT. 116. Members of Adenovirus Subgroup B Utilize CD80 (B7.1) and CD86 (B7.2) as Primary Cellular Attachment Receptors Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.082 | 0.556 | |||
2003 | Takayama K, Reynolds PN, Short JJ, Kawakami Y, Adachi Y, Glasgow JN, Rots MG, Krasnykh V, Douglas JT, Curiel DT. A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism. Virology. 309: 282-93. PMID 12758175 DOI: 10.1016/S0042-6822(03)00067-9 | 0.502 | |||
Show low-probability matches. |